Symposium
Sergio Gianesini, MD, PhD, FACS
UIP President-Elect
University of Ferrara
USUHS University
rovigo, Veneto, Italy
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Robert J. Damstra, MD PhD (he/him/his)
dermatologist
Expert center for lymph-vascular medicine (ECL) Nij Smellinghe hospital
University of Groningen (UMCG)
Beetsterzwaag, Friesland, Netherlands
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Sanjiv Lakhanpal, MD, FACS, DABVLM
President & CEO
Center for Vein Restoration
Greenbelt, MD, United States
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.
Aleksandra Jaworucka- Kaczorowska, MD, PhD
Director and Consultant
Center of General and Vascular Surgery, Obstetrics and Gynecology; Center of Phlebology and Aesthetic Medicine
Gorzów Wlkp, Lubuskie, Poland
Disclosure(s): Alfasigma: Speaker/Honoraria; Balton: Research Grant; Medi: Speaker/Honoraria
Elsina R. Brouwer, RN (she/her/hers)
Chair
NVFL
Amersfoort, Gelderland, Netherlands
Disclosure information not submitted.
Sarah Thomis, PhD
Vascular surgeon
University Hospitals Leuven
Catholic University Leuven
Herent, Vlaams-Brabant, Belgium
Disclosure(s):
The forementioned Program Planner, Faculty, Author, Moderator, or Speaker, has declared for this educational activity, having no relevant financial relationship(s) with ineligible companies to disclose. or AVLS has reviewed / mitigated there are no relevant financial relationships with ineligible companies.